Freshpet, Inc. (FRPT) Stock Price & Analysis
Freshpet, Inc. (FRPT) closed at USD 67 on Thursday, October 22, 2026, up 7.06% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 62.58; the Oct 22, 2026 session ranged USD 62.83–67.37 on volume of 1,332,513 shares. Market capitalization is $3.22B, with a 52-week range of USD 46.45–86 (NGM). Source: Nexqual, retrieved October 23, 2026 at 10:37 UTC.
Also available as compact Markdown for AI agents: nexqual.com/FRPT.md
Key facts (FRPT)
- Last four reported quarters (through Jun 30, 2026): revenue $1.18B, net income $203M (17.3% margin), free cash flow $61.0M (SEC filings).
- Valuation: P/E 15.8x (avg 91.5x at the last 2 fiscal year-ends).
- Earnings quality: non-operating income $62.9M vs operating income $95.4M over the last four quarters; P/E excluding non-operating income ≈22.9x (estimate: non-operating income taxed at the company's 0% effective rate).
- 1 of 80 tracked superinvestors hold FRPT (13F, Q2 2026): 1 new, 0 added, 0 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 10 Form 4 filings, $33.2M; 0 not under a Rule 10b5-1 plan ($0K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Insider open-market purchases, last ~7 months: 7 Form 4 filings, $523K; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Buy (mean 2.11 on a 1–5 scale) (18 analysts), mean target USD 83.31 (range 67–104).
- Total return with dividends: 1Y +23.6% vs S&P 500 +14.9%; 5Y -56.3% vs S&P 500 +80.3%.
- Next earnings: 2026-11-04, EPS estimate USD 0.36, revenue estimate $310M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (FRPT)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $425M | $595M | $767M | $975M | $1.10B | $1.18B |
| Gross profit | $162M | $186M | $251M | $396M | $450M | — |
| Operating income | -$24.7M | -$52.0M | -$30.4M | $38.0M | $75.7M | $95.4M |
| Net income | -$29.7M | -$59.5M | -$33.6M | $46.9M | $139M | $203M |
| EPS (diluted) | -$0.69 | -$1.29 | -$0.70 | $0.93 | $2.64 | — |
| Free cash flow | -$321M | -$273M | -$163M | -$32.8M | $12.4M | $61.0M |
| Gross margin | 38.1% | 31.2% | 32.7% | 40.6% | 40.8% | — |
| Operating margin | -5.8% | -8.7% | -4.0% | 3.9% | 6.9% | 8.1% |
| Net margin | -7.0% | -10.0% | -4.4% | 4.8% | 12.6% | 17.3% |
| Revenue growth | +33.5% | +39.9% | +28.8% | +27.2% | +13.0% | — |
| Cash + short-term investments | $72.8M | $153M | $297M | $269M | — | — |
| Total debt | $0K | $0K | $393M | $395M | $397M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (FRPT)
P/E 15.8x · P/E ex non-operating (est.) ≈22.9x · P/S 2.7x · P/FCF 52.7x · P/B 2.6x · FCF yield 1.90% · Earnings yield 6.32%
P/E at fiscal year-ends: Dec 2025 24.5x, Dec 2024 158.6x.
Superinvestors (SEC 13F-HR, Q2 2026) (FRPT)
1 of 80 tracked investors hold FRPT. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Glenn Welling | Engaged Capital | 8.87% | $28.7M | New position |
Insider sales (SEC Form 4, open-market, last ~7 months) (FRPT)
10 of 10 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-08-26 | Cyr William B. | Chief Executive Officer | 39,664 | $3.0M | 6.2% | Yes (adopted November 5, 2025) | Too little history (no open-market trades in 2023–2025) |
| 2026-08-21…2026-08-24 | Cyr William B. | Chief Executive Officer | 87,905 | $6.6M | 13.4% | Yes (adopted November 5, 2025) | Too little history (no open-market trades in 2023–2025) |
| 2026-08-19 | Cyr William B. | Chief Executive Officer | 44,078 | $3.3M | 8.3% | Yes (adopted November 5, 2025) | Too little history (no open-market trades in 2023–2025) |
| 2026-08-17 | Cyr William B. | Chief Executive Officer | 44,067 | $3.2M | 9% | Yes (adopted November 5, 2025) | Too little history (no open-market trades in 2023–2025) |
| 2026-08-14 | Cyr William B. | Chief Executive Officer | 44,069 | $3.2M | 9.8% | Yes (adopted November 5, 2025) | Too little history (no open-market trades in 2023–2025) |
| 2026-05-22 | Cyr William B. | Chief Executive Officer | 46,814 | $2.4M | 11.3% | Yes (adopted November 5, 2025) | Too little history (no open-market trades in 2023–2025) |
| 2026-05-20 | Cyr William B. | Chief Executive Officer | 47,582 | $2.3M | 12.6% | Yes (adopted November 5, 2025) | Too little history (no open-market trades in 2023–2025) |
| 2026-05-15…2026-05-18 | Cyr William B. | Chief Executive Officer | 94,364 | $4.6M | 24.3% | Yes (adopted November 5, 2025) | Too little history (no open-market trades in 2023–2025) |
| 2026-05-13 | Cyr William B. | Chief Executive Officer | 46,818 | $2.3M | 17.6% | Yes (adopted November 5, 2025) | Too little history (no open-market trades in 2023–2025) |
| 2026-05-11 | Cyr William B. | Chief Executive Officer | 46,502 | $2.4M | 20.3% | Yes (adopted November 5, 2025) | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Insider purchases (SEC Form 4, open-market, last ~7 months) (FRPT)
7 purchases, $523K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-09-14 | George Walter N. | Director | 1,000 | $65K | 64.92 | Too little history (no open-market trades in 2024) |
| 2026-05-20 | Brewster Daryl G | Director | 211 | $10K | 47.52 | Too little history (no open-market trades in 2023 or 2024) |
| 2026-05-20 | Steeneck Craig D. | Director | 2,000 | $96K | 47.83 | Too little history (no open-market trades in 2023 or 2024) |
| 2026-05-18 | McLevish Timothy R | Director | 3,000 | $146K | 48.67 | Too little history (no open-market trades in 2023 or 2024) |
| 2026-05-18 | Biegger David | Director | 1,000 | $49K | 49.14 | Too little history (no open-market trades in 2023 or 2024) |
| 2026-05-18 | Kelley Jacki Sue | Director | 1,000 | $48K | 48.05 | Too little history (no open-market trades in 2023 or 2024) |
| 2026-05-08 | George Walter N. | Director | 2,000 | $109K | 54.67 | Too little history (no open-market trades in 2024) |
Analysts (FRPT)
Consensus Buy (mean 2.11 on a 1–5 scale), 18 analysts; mean target USD 83.31 (low 67, high 104).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-13 | TD Cowen | Target lowered | Buy | $85 → $80 |
| 2026-10-05 | Wells Fargo | Target lowered | Overweight | $82 → $77 |
| 2026-10-01 | Needham | Initiated | Hold | |
| 2026-08-06 | DA Davidson | Target lowered | Buy | $101 → $95 |
| 2026-08-06 | TD Cowen | Target raised | Buy | $80 → $85 |
| 2026-08-06 | Stifel | Target raised | Buy | $66 → $78 |
| 2026-08-06 | Morgan Stanley | Downgrade | Overweight → Equal-Weight | $77 → $72 |
| 2026-07-28 | JP Morgan | Target raised | Overweight | $68 → $72 |
| 2026-07-08 | Wells Fargo | Target lowered | Overweight | $75 → $70 |
| 2026-07-01 | B of A Securities | Target lowered | Neutral | $75 → $70 |
Total return (dividends reinvested) (FRPT)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +23.6% | -56.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +23.7% | -15.2% |
| Volatility (annualized) | 48.6% | 51.4% |
| Max drawdown | -44.6% (Mar 2026→May 2026) | -74.7% (Oct 2021→Sep 2022) |
FRPT suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | Walmart (WMT) | “In 2025, our largest distributor by net sales accounted for less than 10% of our net sales and our largest customers, Walmart and Costco, accounted for 25% and 10% of our net sales, respectively.” |
| Customer | Costco (COST) | “In 2025, our largest distributor by net sales accounted for less than 10% of our net sales and our largest customers, Walmart and Costco, accounted for 25% and 10% of our net sales, respectively.” |
Quoted from the company's 10-K filed Feb 23, 2026.
FRPT customer concentration
In the period ended Jun 30, 2026, 3 direct customers each accounted for at least 10% (25%, 12%, 7%) of revenue, per the company's 10-Q filed Aug 5, 2026. The company does not name them.
FRPT analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.36 | $0.37 | -4.7% | $310.3M | 4 |
| Next quarter (ends Dec 2026) | $0.56 | $0.62 | -10.2% | $312.8M | 4 |
| Current fiscal year (ends Dec 2026) | $1.67 | $1.68 | -0.9% | $1.23B | 5 |
| Next fiscal year (ends Dec 2027) | $1.94 | $1.80 | +7.7% | $1.33B | 6 |
Key Statistics (as of October 23, 2026 at 10:37 UTC)
| Price | USD 67 |
|---|---|
| Change | ▲ 7.06% (up) |
| Previous Close | USD 62.58 |
| Open | USD 63.04 |
| Day Range | USD 62.83 – 67.37 |
| 52-Week Range | USD 46.45 – 86 |
| Volume | 1,332,513 shares |
| Market Cap | $3.22B |
| Exchange | NGM |
Technical Analysis (FRPT)
Nexqual's technical model rates FRPT "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of October 23, 2026 at 10:37 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 54.08 (neutral) |
| vs SMA50 | Above (USD 66.18) |
| MACD | 0.72 (positive) |
Analyst Ratings (FRPT)
Wall Street analysts rate FRPT "Buy" based on 18 analysts, with a mean price target of USD 83.31 (range USD 67–104), per Nexqual as of October 23, 2026 at 10:37 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 18 |
| Mean Target | USD 83.31 |
| High Target | USD 104 |
| Low Target | USD 67 |
| Buy / Hold / Sell | 13 / 5 / 0 |
Earnings (FRPT)
| Next Earnings Date | 2026-11-04 |
|---|---|
| EPS Estimate | USD 0.36 |
| Revenue Estimate | $310.32M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.29 vs est 0.22 ▲ beat |
| 2026-03-31 | USD 0.17 vs est 0.09 ▲ beat |
| 2025-12-31 | USD 0.62 vs est 0.48 ▲ beat |
| 2025-09-30 | USD 1.83 vs est 0.4 ▲ beat |
Source: Nexqual, October 23, 2026 at 10:37 UTC.
Financials & Fundamentals (FRPT)
| Total Revenue | $1.18B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +15.50% |
| Gross Margin | +41.37% |
| Operating Margin | +7.11% |
| Profit Margin | +17.28% |
| ROE | +17.62% |
| Debt / Equity | 0.4 |
| Current Ratio | 6.05 |
| Total Cash | $350.81M |
| Total Debt | $493.66M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $61.05M (5.2% of revenue) |
Source: Nexqual, October 23, 2026 at 10:37 UTC.
Financial Health Score (FRPT)
Nexqual rates Freshpet, Inc.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 10:37 UTC.
| Growth | Solid — Revenue +13% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 41%, operating 7% (last 12 months) |
| Balance Sheet | Strong — $351M cash vs $494M debt |
| Cash Flow | Solid — FCF $61M (last 4 quarters to Jun 2026, SEC), 5% margin |
| Efficiency | Solid — ROE 18%, ROA 3.5% |
Ownership (FRPT)
| Insider Ownership | +2.07% |
|---|---|
| Institutional Ownership | +134.21% |
| Shares Outstanding | 48.06M |
| Float | 46.92M |
| Short % of Float | +19.43% |
Source: Nexqual, October 23, 2026 at 10:37 UTC.
Leadership (FRPT)
Freshpet, Inc. is led by William B. Cyr, CEO & Executive Director, per Nexqual as of October 23, 2026 at 10:37 UTC.
| CEO & Executive Director | William B. Cyr |
|---|---|
| Senior Vice President of Finance | Ivan Garcia |
| Chief Financial Officer | John O'Connor |
| Vice President of Investor Relations & Corporate Communications | Rachel Perkins-Ulsh |
| Senior Vice President of Sales | Thomas Farina |
Major Backers & Investors (FRPT)
Notable institutional backers of Freshpet, Inc. include Capital Group, SmallCap World Fund Inc, Wasatch Advisors LP, according to Nexqual as of October 23, 2026 at 10:37 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Capital Group | 6.19% |
| SmallCap World Fund Inc | 6.03% |
| Wasatch Advisors LP | 5.99% |
| Wellington Management | 5.76% |
| Bank of Montreal /CAN/ | 4.04% |
| Alliancebernstein L.P. | 3.82% |
| William Blair Investment Management, LLC | 3.69% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 11.98% |
| Vanguard Group | 10.51% |
| State Street | 3.26% |
Source: Nexqual, October 23, 2026 at 10:37 UTC.
From Freshpet, Inc.'s Latest SEC 10-K Filing (filed 2026-02-23)
Key Strengths & Strategy (as disclosed to the SEC)
- Our proprietary recipes include real, fresh meat and poultry products and varying combinations of vitamin-rich vegetables, leafy greens and antioxidant rich fruits, without the use of preservatives or additives.
- We are continually developing new technology and enhancing proprietary technology related to our pet food, Freshpet Fridges and manufacturing operations.
- Our commitment to our values helps us engage with consumers, motivate our team members, and attract strong partners, which allows us to fulfill our mission of delivering the best nutritional product choices to improve the well-being of our pets, enrich pet parents' lives, and contribute to communities.
- Our unique product attributes appeal to diverse consumer needs across multiple classes of retail where Freshpet is sold.
Legal & Regulatory Risks (Item 1A, quoted)
- Government regulation, scrutiny, warnings and public perception could increase our costs of production and increase legal and regulatory expenses.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INGR | Ingredion Incorporated | USD 97.18 | ▲ 1.57% |
| CPB | The Campbell's Company | USD 21.26 | ▲ 8.69% |
| PPC | Pilgrim's Pride Corporation | USD 28.09 | ▲ 1.23% |
| CAG | ConAgra Brands, Inc. | USD 15.07 | ▲ 7.34% |
| SFD | Smithfield Foods, Inc. | USD 18.81 | ▲ 2.79% |
| LW | Lamb Weston Holdings, Inc. | USD 55.18 | ▲ 3.9% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 10:37 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt